Neurology devices are specialized surgical devices used for the treatment of disease or conditions of the central nervous system (CNS) and spine. Minimally invasive neurosurgical devices are used to enable neurosurgery without large incisions into the skull. GlobalData uses proprietary data and analytics to provide a comprehensive report on the minimally invasive neurosurgical devices market in China. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the minimally invasive neurosurgical devices market in China was Integra LifeSciences followed by Misonix, NICO, Penumbra, Stryker and Vycor Medical.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Minimally Invasive Neurosurgical devices aim to maximize visualization of cranial tissue while reducing post-operative complications during surgical procedures. Disposable handpieces, ultrasonic aspiration disposable tips and subcortical access devices are tracked under this segment. Disposable handpieces are used for the removal of cranial tissues. Ultrasonic aspiration disposable tips use vibration to create negative pressure in the targeted tissue. Subcortical access devices consist of ports that are specially designed to allow surgeons access to the subcortical area of the brain.

The minimally invasive neurosurgical devices market in China can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size minimally invasive neurosurgical devices in China, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.